Common flu vaccine linked to lower Alzheimer's risk when dose is increased

A UTHealth analysis of nearly 200,000 adults aged 65 and older found that those who received a high-dose influenza vaccine had a lower reported risk of developing Alzheimer's disease than those who received the standard dose; the authors and outside experts say the study shows an association, not proof of causation.

A new analysis led by researchers at The University of Texas Health Science Center at Houston reports an association between higher-dose influenza vaccination and lower Alzheimer’s disease risk in older adults. The study examined medical records for nearly 200,000 people aged 65 and older. Researchers compared outcomes for people who received high-dose influenza vaccine, standard-dose vaccine, or no vaccine. The authors and outside commentators emphasized that the work shows a link rather than a proven cause-and-effect relationship. Key findings: - The analysis found that adults 65 and older who received a high-dose flu vaccine had a lower reported risk of Alzheimer’s compared with those who received a standard dose. - The high-dose influenza vaccine is roughly four times the antigen strength of the standard shot and is recommended by the Centers for Disease Control and Prevention for people aged 65 and older. - In the study, people who received the high-dose vaccine had an almost 55% lower risk than those who were not vaccinated, and prior related research reported about a 40% reduction associated with any flu vaccination. - The protective association was reported as more pronounced in women, although both sexes showed benefits. - Authors and independent experts noted the study used retrospective medical records, which can leave room for missing data and confounding factors; they emphasized the result is an association, not proof that the vaccine caused the effect. - A commentator noted that vaccine components do not cross the blood-brain barrier and suggested any effect might be indirect, for example through immune or inflammatory pathways. Summary: The reported association suggests a stronger influenza vaccine dose was linked with lower recorded rates of Alzheimer’s disease among older adults in this dataset. Researchers say further study is needed to test causation, to understand possible biological mechanisms, and to examine timing and other factors that could influence the relationship. Undetermined at this time.